Vaxxas’ proprietary high-density microarray patch (HD-MAP) technology is currently being evaluated in a phase 1 clinical study of the first needle-free COVID-19 vaccine, having demonstrated ...

The European Patent Office has said it has invalidated a patent held by Moderna on mRNA-based COVID-19 vaccines, the latest development in an increasingly acrimonious dispute between the company ...

GCSE examinations in 2023 will mainly return to pre-pandemic arrangements, after several years of disruption due to Covid-19. Dr Jo Saxton from Ofqual said "I can confirm that, in 2023 ...